Medicine
Zirgan 0.15% ophthalmic gel
Zirgan 0.15% ophthalmic gel is a prescription medicine containing Ganciclovir for ophthalmic use, marketed by Bausch & Lomb, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store at 15°C to 25°C (59°F to 77°F).
Key facts
- Active ingredient (INN)
- Ganciclovir
- Brand
- Zirgan
- Strength
- 0.15%
- Dosage form
- Ophthalmic gel
- Route
- Ophthalmic
- Packs
- 1 tube
- Marketing authorisation holder
- Bausch & Lomb
- Manufacturer
- Bausch & Lomb
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at 15°C to 25°C (59°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AB06 Ganciclovir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 April 2010
- Identifiers
- RxCUI 388052, 864650DailyMed set ID ea25e7ac-7a93-4ec8-975b-2cec197e1c27NDC 24208-535Application NDA022211
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube, with applicator in 1 carton / 1.5 g in 1 tube, with applicator | 24208-535-15 | Bausch & Lomb | 30 April 2010 |
| 1 tube, with applicator in 1 carton / 5 g in 1 tube, with applicator | 24208-535-35 | Bausch & Lomb | 30 April 2010 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ganciclovir
Clinical summary
Ganciclovir is a cytomegalovirus nucleoside analog DNA polymerase inhibitor indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in adults and pediatric patients aged 2 years and older. MedsAcross supplies Ganciclovir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GanciclovirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ZIRGAN prescribing information (Bausch & Lomb) · U.S. National Library of Medicine, DailyMed
Need Zirgan 0.15% ophthalmic gel for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.